Bevacizumab Plus Fluorouracil: The Value of Being Part of a Developing Story-Reference-Cited by-同舟云学术

Bevacizumab Plus Fluorouracil: The Value of Being Part of a Developing Story

Published:2005-06-01 Issue:16 Volume:23 Page:3660-3662
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Sobrero Alberto¹,Bruzzi Paolo¹

Affiliation:

1. Ospedale S. Martino and Istituto Nazionale Ricerca Cancro, Genova, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.11.941

Reference15 articles.

1. Two Steps Forward in the Treatment of Colorectal Cancer

2. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

3. Kabbinavar FF, Shulz J, McCleod M, et al: Addition of bevacizumab to bolus fluorouracil/leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial. J Clin Oncol 23: 10.1200/JCO.2005.05.112

4. Hurwitz H, Fehrenbacher L, Cartwright T, et al: Bevacizumab prolongs survival in first line colorectal patients: Results of a phase III trial of bevacizumab in combination with bolus IFL as first line therapy in subjects with metastatic colorectal cancer. Proc Am Soc Clin Oncol 22: 2003 (abstr 3646)

5. Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases;Anti-Cancer Drugs;2009-04

2. Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report;Targeted Oncology;2008-10

3. EGFR and colon cancer: a clinical view;Clinical and Translational Oncology;2008-01

4. Bevacizumab in the treatment of metastatic colorectal cancer;Future Oncology;2007-04

5. Cetuximab in Colon Cancer;The International Journal of Biological Markers;2007-01